Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

8.76
Delayed Data
As of Sep 23
 -0.07 / -0.79%
Today’s Change
6.00
Today|||52-Week Range
13.18
-16.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues7.6M30.6M46.9M28.7M
 
 
 
 
 
Depreciation And Amortization591.0K433.0K490.0K589.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses47.5M64.1M61.2M65.5M
 
 
 
 
 
Research And Development35.6M49.5M44.4M46.4M
 
 
 
 
 
Total Operating Expenses48.1M64.5M61.7M66.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.5M-33.9M-14.8M-37.4M
 
 
 
 
 
Extraordinary Credit56.0K0.000.000.00
 
 
Interest Expense On Debt2.0K--0.00250.0K
 
 
 
Other Expenses0.0079.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.4M-33.7M-14.6M-37.5M
 
 
 
 
 
Preferred Dividend-1.3M0.000.000.00
 
 
Net Income-40.4M-33.7M-14.6M-37.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.1M27.3M35.7M38.8M
 
 
 
 
 
Shares To Calculate EPS Diluted18.1M27.3M35.7M38.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.28-$1.24-$0.41-$0.97
 
 
 
 
 
EPS Diluted-$2.28-$1.24-$0.41-$0.97